Lead Financial Analyst, LATAM & Canada GDCL
Johnson & Johnson Services, Inc.
- Local
- Guarulhos, São Paulo
- Modelo
- Presencial
- Contrato
- Tempo integral
Sobre a vaga
At Johnson & Johnson, we believe health is everything. Nossa força em inovação na área da saúde nos capacita a construir um mundo em que doenças complexas são prevenidas, tratadas e curadas, em que os tratamentos são mais inteligentes e menos invasivos e as soluções são pessoais. Por meio de nossa experiência em medicina inovadora e tecnologia médica, estamos em uma posição única para inovar em todo o espectro de soluções de saúde hoje para entregar os avanços do futuro e impactar profundamente a saúde da humanidade. Learn more at jnj.com.
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. Devemos oferecer um ambiente de trabalho inclusivo, em que cada pessoa precisa ser considerada como um indivíduo. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function
Finance
Job Sub Function
Finance Business Partners
Job Category
Professional
All Job Posting Locations
Guarulhos, São Paulo, Brazil
Job Description
Johnson & Johnson is hiring for a Lead Financial Analyst, LATAM & Canada GDCL within the MedTech DePuy Synthes organization. DePuy Synthes is the world’s leading orthopedics company, with approximately $9B in annual revenue across multiple platforms. This role can be based in any of the following DePuy Synthes office locations in Latin America, Canada, and the United States.
Johnson & Johnson announced plans to separate our Orthopaedics business to establish a standalone orthopaedics company, operating as DePuy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals.
Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes, and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans. In that case, details of any planned changes would be provided to you by DePuy Synthes at an appropriate time and subject to any necessary consultation processes.
Please note that this role is available across multiple countries and may be posted under different requisition numbers to comply with local requirements. While you are welcome to apply to any or all of the postings, we recommend focusing on the specific country(s) that align with your preferred location(s):
US - Requisition Number: R-108561
Canada - Requisition Number: R-109987
Brazil- Requisition Number: R-109973
Costa Rica - Requisition Number: R-109982
Columbia – Requisition Number: R-109984
Remember, whether you apply to one or all of these requisition numbers, your applications will be considered as a single submission.
Key Responsibilities
The Lead Analyst will be responsible for owning, validating, and tracking the organization’s financial performance and cost-to-serve model with GDCL business partners in Latin America and Canada. Additionally, they will ensure that financial commitments are met by advising distribution, transportation, and customer service teams in budget management and resource allocation while proactively identifying opportunities to optimize expenditure and capital investments. This role requires completing financial forecasts (BP, JU, NU, Latest Thinkings), reporting, and analysis of complex financial data that will help influence decision and set strategy. Support of monthly, quarterly, and annual financial close activities, including consolidation, analysis, and reporting is required.
The candidate must have demonstrated strong processional judgement as the role is accountable for maintaining strong compliance discipline. Financial priorities include market share and gross profit improvement, lowering the cost to serve, and improved uti
